Seed-Assisted Effects on Solution-Mediated Phase Transformation: A Case Study of L-Histidine in Antisolvent Crystallization

被引:11
作者
Liu, Ya [1 ,3 ]
Xu, Shijie [1 ,3 ]
Liu, Yumin [1 ,3 ]
Chen, Mingyang [1 ,3 ]
Chen, Yifu [1 ,3 ]
Du, Shichao [1 ,3 ]
Wang, Yaping [1 ,3 ]
Sun, Panpan [1 ,3 ]
Sun, Mengmeng [1 ,3 ]
Shi, Peng [1 ,3 ]
Gong, Junbo [1 ,2 ,3 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China
[2] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin 300072, Peoples R China
[3] Coinnovat Ctr Chem & Chem Engn Tianjin, Tianjin 300072, Peoples R China
基金
中国国家自然科学基金;
关键词
INDUCTION TIME MEASUREMENT; L-GLUTAMIC ACID; POLYMORPHIC TRANSFORMATION; CRYSTAL-STRUCTURE; NUCLEATION; GROWTH; FORM; QUANTIFICATION; CARBAMAZEPINE; SPECTROSCOPY;
D O I
10.1021/acs.iecr.7b04762
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In this study, the effects of crystal nucleation growth on subsequent solvent-mediated phase transformation experiments of L-histidine (L-his) in antisolvent crystallization were performed at 298.15 K. The unexpected acceleration of the overall transformation rate in antisolvent crystallization with solution-mediated phase transformation was found for a methanol volume fraction of 0.35 < x(2) < 0.60. Interestingly, concomitant polymorphs were obtained for a methanol volume fraction of 0.30 <= x(2) <= 0.65 in antisolvent crystallization, whereas only form B was observed for other volume fractions of methanol, which indicated that the concomitant polymorphic phenomenon was the main reason for the accelerated transformation rate in antisolvent crystallization. Furthermore, seed-assisted experiments and suspended solution-mediated phase transformation experiments were designed to uncover the role of the nucleation of form A accompanying with form B in the subsequent transformation process.
引用
收藏
页码:784 / 793
页数:10
相关论文
共 36 条
[1]  
Bernstein J, 1999, ANGEW CHEM INT EDIT, V38, P3440, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO
[2]  
2-#
[3]  
Brittain H.G., 2009, Polymorphism in Pharmaceutical Solids
[4]   Mechanistic Features of Polymorphic Transformations: The Role of Surfaces [J].
Croker, D. ;
Hodnett, B. K. .
CRYSTAL GROWTH & DESIGN, 2010, 10 (06) :2806-2816
[5]   A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam [J].
Croker, Denise M. ;
Hennigan, Michelle C. ;
Maher, Anthony ;
Hu, Yun ;
Ryder, Alan G. ;
Hodnett, Benjamin K. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 63 :80-86
[6]   Nucleation control in solution mediated polymorphic phase transformations: The case of 2,6-dihydroxybenzoic acid [J].
Davey, RJ ;
Blagden, N ;
Righini, S ;
Alison, H ;
Ferrari, ES .
JOURNAL OF PHYSICAL CHEMISTRY B, 2002, 106 (08) :1954-1959
[7]   RATE CONTROLLING PROCESSES IN SOLVENT-MEDIATED PHASE-TRANSFORMATIONS [J].
DAVEY, RJ ;
CARDEW, PT ;
MCEWAN, D ;
SADLER, DE .
JOURNAL OF CRYSTAL GROWTH, 1986, 79 (1-3) :648-653
[8]   Solution-Mediated Polymorphic Transformation of Prasugrel Hydrochloride from Form II to Form I [J].
Du, Wei ;
Yin, Qiuxiang ;
Hao, Hongxun ;
Bao, Ying ;
Zhang, Xia ;
Huang, Jiting ;
Li, Xiang ;
Xie, Chuang ;
Gong, Junbo .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2014, 53 (14) :5652-5659
[9]   Solution-mediated transformation of α to β L-glutamic acid:: Rate enhancement due to secondary nucleation [J].
Ferrari, ES ;
Davey, RJ .
CRYSTAL GROWTH & DESIGN, 2004, 4 (05) :1061-1068
[10]  
Gu CH, 2001, J PHARM SCI-US, V90, P1878, DOI 10.1002/jps.1137.abs